CarboMedics (US) tests aldehyde-free heart valve
This article was originally published in Clinica
CarboMedics (US) says PhotoFix, its non-aldehyde-fixed heart valve, has now been used at three unnamed sites in Europe. Vice-president and general manager Perry Barrs says the valve is a response to the possibility that bioprosthesis calcification may be related to the use of aldehydes in fixing and sterilisation. The trileaflet cardiac aortic valve is made from bovine pericardial tissues and fixed using a patented dye-mediated photo-oxidation process. The implant is sterilised by a non-aldehyde chemical process.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.